Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by CancerSlayer


V.TLT

RE:RE:RE:RE:RE:New Proactive Video

Early innings of "HSV-1 research"...sorry for the unsettling...

September 4, 2024

V.TLT

RE:RE:New Proactive Video

Tarbaby wrote: Have they actually studied Ruvidar for HSV treatment in small...

September 4, 2024

V.TLT

RE:New Investments

Bigkahuna57 wrote: I can't figure out why/how Health Canada has not...

September 3, 2024

V.TLT

RE:Food for thought...

wildbird1 wrote: Food for thought (Part 1)... ImmunityBio-Anktiva(N803+BCG...

September 2, 2024

V.TLT

RE:RE:Audience survey of uro-oncologists

DJDawg wrote: I'm posting this comment as part of an old post so that...

September 1, 2024

V.TLT

RE:RE:RE:RE:RE:It’s allllllll talk

Infinity wrote: A very likely and all familiar scenario that keep repeating...

September 1, 2024

V.TLT

RE:RE:Merck could use some help

O12009 wrote:  Keytruda has been Merck’s can’t-miss drug, rapidly...

August 30, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:INVESTORS ARENT BUYING IT YET

Dawg must have me on ignore ; )...

August 25, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:INVESTORS ARENT BUYING IT YET

Eoganacht wrote: Hi CancerSlayer - I completely agree that the way DOR is...

August 25, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:INVESTORS ARENT BUYING IT YET

Bigkahuna57 wrote: @CS, please correct me if I don't recall these details...

August 25, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:INVESTORS ARENT BUYING IT YET

Per FDA guidance (August 2024, Revision I), the primary efficacy endpoint for...

August 25, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:INVESTORS ARENT BUYING IT YET

Gooseybear wrote: If you think that the FDA regulators don't talk to...

August 25, 2024

V.TLT

RE:RE:RE:RE:In the pipeline...

The first tranche is in....& my hope is the 2nd (& bigger) tranche...

August 23, 2024

V.TLT

RE:RE:RE:In the pipeline...

Mikee3003 wrote: In the pipeline....lol! Get real....bladder is the end game...

August 23, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:POTENTIAL HOME CANCER TREATMENT

wildbird1 wrote: Excellent post CancerSlayer... To complement your post..In...

August 22, 2024

V.TLT

RE:Not photodynamic therapy

Eoganacht wrote: To state the obvious, if Metaformin can successfully...

August 22, 2024

V.TLT

RE:RE:RE:Research Capital?

Yep...at least DIDs are always preceded by IFs ; ).  Keep the faith...

August 21, 2024

V.TLT

RE:Research Capital?

livermore2 wrote: Anyone know why they don't seem to cover theralase any...

August 21, 2024

V.TLT

RE:CLARIFICATION NEEDED FROM CO.

Tarbaby wrote: By stating that Metformin can potentially activate Rutherrin...

August 21, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:POTENTIAL HOME CANCER TREATMENT

Rutherrin & TLD 1433 are practically twins from a biological safety...

August 21, 2024

Featured Company